Institutional Perspectives in Cancer- Precision Medicine: Chaired by Kelvin Paul Lee, MD

Video

In Partnership With:

Institutional Perspectives in Cancer- Precision Medicine: Chaired by Kelvin Paul Lee, MD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers:

  • Chris Fausel, PharmD, MHA, BCOP | Indiana University
  • Bryan P. Schneider, MD | Indiana University

Topics:

  • Biomarker Utilization of Genomic Sequencing Reports with the use of a Molecular Tumor Board
  • Practical Application of Precision Oncology Genomics to a Busy Oncology Practice
  • Novel Drugs Changing the Treatment Landscape for Precision Oncology – case studies (thoracic)
  • Case studies:(Gastrointestinal)
  • Case studies:(Genitourinary)

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Shridar Ganesan, MD, PhD
In this fifth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss the need for evidence to support the utilization of different artificial intelligence tools in healthcare.
Alan Tan, MD
In this fourth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain the importance of having a diverse editorial board behind a new journal on artificial intelligence in precision oncology.
Christopher M. Gallagher, MD
Institutional Perspectives in Cancer: Lung Cancer - Chaired by Lyudmila Bazhenova, MD
Howard S. Hochster, MD
In this third episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss the launch of a new journal that will focus on educating the field on the latest research efforts being made with artificial intelligence.
In this second episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, explain how artificial intelligence tools may be leveraged in the oncology field to provide personalized care.
Misty D. Shields, MD, PhD